Sunday, June 10, 2018

Dalbavancin Protocol in ED Effective for Skin Infections

(MedPage Today) -- Use of long-acting IV lipoglycopeptide antibiotic also cut hospital admissions

1 comment:

  1. Dalbavancin (INN, trade name Dalvance) is a novel second-generation lipoglycopeptide antibiotic. It belongs to the same class as vancomycin.The Food and Drug Administration approved dalbavancin for the treatment of acute bacterial skin and skin structure infections caused by certain susceptible bacteria. Dalbavancin

    ReplyDelete